physIQ Heart Rhythm and Respiratory Module vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Tempus AI, Inc.

AI Verdict

Tool A focuses on continuous, real-time monitoring of various physiological parameters, including AFib detection, using wearable biosensor data. Tool B, conversely, uses a single 12-lead ECG to predict the 12-month risk of new-onset atrial fibrillation in a specific older patient population. Therefore, while both address atrial fibrillation in cardiology, their distinct data sources, methodologies, and primary objectives make them complementary rather than direct competitors.

Choose physIQ Heart Rhythm and Respiratory Module if…

Choose physIQ Heart Rhythm and Respiratory Module if you require continuous, real-time physiological monitoring of patients using wearable biosensors to detect subtle changes from an individualized baseline. This tool is ideal for proactive management and early intervention, particularly in critical care, cardiology, or pulmonology settings where continuous insight into heart rhythm and respiratory rate is crucial for identifying decompensation.

View physIQ Heart Rhythm and Respiratory Module →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your primary goal is to identify older patients (65+) at an increased risk of developing new-onset atrial fibrillation within the next 12 months using existing 12-lead ECG data. This solution is best suited for risk stratification and supporting earlier follow-up in a clinical setting, leveraging AI to predict future AF risk rather than providing continuous real-time monitoring.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature physIQ Heart Rhythm and Respiratory Module Tempus ECG-AF
Pricing Contact for pricing Contact vendor
Deployment Cloud-based platform Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

physIQ Heart Rhythm and Respiratory Module

Tool A, physIQ, leverages continuous wearable biosensor data and a cloud-based platform, which can offer greater patient convenience and less intrusive data collection compared to episodic clinical tests. Its remote monitoring capabilities suggest a more flexible and accessible approach to data acquisition for ongoing patient management.

Clinical Value

physIQ Heart Rhythm and Respiratory Module

Tool A provides broader clinical value through AI-based personalized physiology analytics, continuously monitoring for subtle changes, early signs of decompensation, heart rate, respiration rate, and atrial fibrillation. This comprehensive, real-time, and personalized insight from continuous data offers a wider range of actionable clinical information than Tool B's specific predictive risk for AFib from a single ECG.

Pricing & Value

Tempus ECG-AF

Tool B, Tempus ECG-AF, explicitly details CMS reimbursement availability with specific CPT codes and a Medicare rate, providing clear financial transparency and a strong value proposition for healthcare providers. Tool A, physIQ, only states 'contact for pricing,' offering no immediate insight into its financial viability or reimbursement pathways.

Enterprise Readiness

physIQ Heart Rhythm and Respiratory Module

Both tools are FDA-cleared, HIPAA compliant, and have BAAs, demonstrating strong foundational readiness. However, Tool A explicitly labels itself as an 'industry-leading, enterprise-ready cloud platform,' suggesting a more inherently scalable and flexible infrastructure designed for diverse enterprise integration and deployment needs beyond specific system compatibility.

Innovation

physIQ Heart Rhythm and Respiratory Module

Tool A's innovation lies in its AI-based personalized physiology analytics that learns individual patient baselines and detects subtle, personalized physiological changes from continuous wearable data. This adaptive, continuous learning model for proactive health monitoring represents a more advanced and personalized approach to digital medicine compared to Tool B's predictive algorithm on a standard diagnostic test.

Support & Docs

Tempus ECG-AF

Tool B, Tempus AI, provides explicit contact information for customer support via email and phone, and mentions local representatives, indicating clear channels for assistance. In contrast, no specific support or documentation details for physIQ's Heart Rhythm and Respiratory Module were found in the provided facts or relevant web searches.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature physIQ Heart Rhythm and Respiratory Module Tempus ECG-AF
Name physIQ Heart Rhythm and Respiratory Module Tempus ECG-AF
Company physIQ Tempus AI, Inc.
Primary Data Source Continuous wearable biosensor data 12-lead ECG recordings
Key Functionality AI-based personalized physiology analytics, continuous biosensor data collection, detects subtle physiological changes, calculates heart rate/variability, detects atrial fibrillation, determines respiration rate AI-based algorithm analyzes 12-lead ECGs to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within 12 months
Target Patient Population Not specified Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery

Videos

Demos, reviews, and walkthroughs featuring physIQ Heart Rhythm and Respiratory Module and Tempus ECG-AF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

physIQ Heart Rhythm and Respiratory Module utilizes continuous wearable biosensor data. In contrast, Tempus ECG-AF analyzes 12-lead ECG recordings from FDA-authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems.
physIQ Heart Rhythm and Respiratory Module focuses on generating unprecedented health insight through continuous monitoring, detecting subtle physiological changes, and early signs of decompensation, including atrial fibrillation and respiration rate. Tempus ECG-AF's primary objective is to identify patients aged 65 or older at increased risk of developing new onset atrial fibrillation/flutter within the next 12 months.
The physIQ Heart Rhythm and Respiratory Module is for use in adult patients in subacute clinical and nonclinical settings for remote patient monitoring. Tempus ECG-AF is specifically intended for patients aged 65 or older without pre-existing atrial fibrillation, pacemakers, ICDs, or recent cardiac surgery.
physIQ detects atrial fibrillation through continuous analysis of wearable biosensor data and personalized physiology analytics. Tempus ECG-AF uses an AI-based algorithm to analyze a single 12-lead ECG recording to predict the risk of new onset atrial fibrillation/flutter within 12 months.
Tempus ECG-AF has CMS reimbursement available, with CPT codes 0764T and 0765T to APC 5734, at a Medicare rate of $128.90, effective January 1, 2025. The provided information for physIQ does not specify reimbursement details.
AI Tool Finder
AI-powered search. Results may not be comprehensive.